Home LiteratureArticle Details
PMID: 3999352 Published · ppublish English Case Reports Journal Article

A recommended approach to the evaluation of human rabies exposure in an acute-care hospital.

JAMA ·Vol. 254 ·No. 1 ·1985-07-05 ·Pages 67-9

Remington PL, Shope T, Andrews J

Abstract

It is important to minimize the costs and risks associated with unnecessary prophylaxis of health care workers. We studied the process of providing rabies postexposure prophylaxis following the 24-day hospitalization of a rabies-infected patient. Of 209 persons who cared for the patient, only 12 (6%) reported high-risk contact, and treatment was recommended for them. Unnecessary prophylaxis was limited to 35 persons (18%) who did not report high-risk contacts but who requested treatment because of their uncertainty about the degree of exposure. These persons, however, spent significantly more time with the patient compared with persons who did not request treatment. Maintaining strict isolation precautions when rabies is being considered, educating employees about the risks of transmission in this setting, carefully documenting exposures, and adhering to the guidelines for postexposure prophylaxis may help reduce excessive prophylaxis of health care workers.

MeSH Terms
Adult Body Fluids Child, Preschool Female Hospitals, University Humans Male Michigan Occupational Diseases/prevention & control Personnel, Hospital Rabies/prevention & control,transmission Risk Surveys and Questionnaires
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Remington P L
Shope T
Andrews J
Article Info
Journal
JAMA
Abbr.
JAMA
ISSN
0098-7484
Published
1985-07-05
Pages
67-9
Language
English
Region
United States
NLM ID
7501160
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com